• About us

    The 9th largest veterinary pharmaceutical company in the world, Vetoquinol is first and foremost an independent, family-owned business.Deeply committed to its values, it has always enjoyed a close relationship with its vet clients.

  • Working at Vetoquinol

      

  • Achieve More Together

    Building trustworthy relationships with all stakeholders in animal health across the globe.

Vetoquinol live

  • 2016 SALES: €350.3 MILLION 4.3% LIKE-FOR-LIKE GROWTH

    26 Jan 2017
    The Vetoquinol Group posted sales of €350.3 million for 2016, representing like-for-like growth of 4.3%. After a negative currency impact of 2.0% mainly linked to the British pound, Canadian dollar and Indian rupee, reported growth amounted to 2.3%.
  • 2017 calendar of financial communication

    12 Dec 2016
    December 12, 2016 (Lure, France) – Vetoquinol published its calendar of financial communication for 2017.
  • SEPTEMBER 2016 YEAR-TO-DATE SALES: €257.5 MILLION A 4.8% ORGANIC GROWTH

    18 Oct 2016
    Vetoquinol posted sales of €257.5 million for the first nine months of 2016, up 2.3% compared to the same period last year. Organic growth for the period came to 4.8%, curbed by a 2.5% negative currency impact. 
  • VETOQUINOL LAUNCHES ITS EMPLOYER BRAND

    29 Sep 2016
    The veterinary pharmaceutical company Vetoquinol launches its employer brand. For 83 years, Vetoquinol has been building its future, drawing on relationships of trust with its partners, the development of every employee, and its long-held belief of continuous improvement. Following on from its corporate brand, the company is now positioning itself as a high-quality employer.
  • 26 january 2017

    2016 Annual revenues (after market)

  • 23 March 2017

    2016 Annual results (after market)

  • 13 april 2017

    2017 First quarter revenues (after market)

  • 30 May 2017

    Annual shareholders’ meeting

Veterinarians

CONTACT US
Find the nearest Vetoquinol contact point by selecting a country website
VETOQUINOL IN THE WORLD